COMMUNIQUÉS West-GlobeNewswire

Kalytera Therapeutics Announces Short Form Prospectus Offering of Units
10/07/2018
/NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES/ SAN FRANCISCO and TEL AVIV, Israel, July 10, 2018 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (the "Company", or “Kalytera”) (TSXV:KALY [...]
IRIDEX Reaches Milestone of 1000th Cyclo G6 System Shipped
10/07/2018
Important Commercial Milestone Demonstrates Growing Worldwide Awareness of MicroPulse Technology for Treatment of Glaucoma MOUNTAIN VIEW, Calif., July 10, 2018 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq:IRIX) today [...]
Progressive Care Launches New Discharge(RX) Program to Improve Engagement Between Patients and Hospitals
10/07/2018
MIAMI, July 10, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD), a personalized healthcare services and technology company, today announced the launch of its new proprietary patient engagement program, [...]
Filament BioSolutions Announces Collaboration with Ajinomoto for the Development of FB-2710 for Radiation-Induced Oral Mucositis
10/07/2018
Filament is expanding its product pipeline to include multiple oncology co-therapies NEW YORK, July 10, 2018 (GLOBE NEWSWIRE) -- Filament BioSolutions, a development-stage company focused on delivering innovative [...]
Collegium Announces Promotion of Scott Dreyer to CCO
10/07/2018
CANTON, Mass., July 10, 2018 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq:COLL) today announced the promotion of Scott Dreyer to the position of Executive Vice President and Chief Commercial Officer, [...]
Emblem inspires Canadians to Get Curious with the launch of new adult-use cannabis brand, Symbl
10/07/2018
PARIS, Ontario, July 10, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV:EMC) (TSXV:EMC.WT) (“Emblem” or the "Company") today announced the launch of its first adult-use cannabis brand, Symbl. Leveraging Emblem’s existing [...]
Pacific Biosciences Selected for NSF Project to Rapidly Sequence Maize Pangenome
10/07/2018
SMRT Sequencing Chosen for Ambitious Effort to Generate Reference Genomes for 26 Maize Lines MENLO PARK, Calif., July 10, 2018 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq:PACB), the leading [...]
Exalenz Bioscience’s Non-Invasive BreathID® Test to be Evaluated in Two Bristol-Myers Squibb Phase 2b Clinical Trials in Adult Patients with NASH
10/07/2018
Studies will use BreathID 13 C-methacetin breath test to evaluate patient response to therapy MODI’IN, Israel and MANASQUAN, N.J., July 10, 2018 (GLOBE NEWSWIRE) -- Exalenz Bioscience Ltd. (TASE:EXEN), a leader in [...]
Avalon GloboCare Appoints Senior Healthcare Executive William Stilley to Board of Directors
10/07/2018
FREEHOLD, N.J., July 10, 2018 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (OTCQB:AVCO), a leading global developer of cell-based technologies, today announced that it has appointed William B. Stilley to the Company’s [...]
VIVUS Announces Positive Results from a Phase 1 Clinical Trial of VI-0106
10/07/2018
-Favorable pharmacokinetic results add to body of data supporting continued development in the treatment of pulmonary arterial hypertension- CAMPBELL, Calif., July 10, 2018 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS [...]
International Stem Cell Corporation Expands Manufacturing Capabilities for Biomedical Products
10/07/2018
CARLSBAD, Calif., July 10, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company developing novel stem cell-based [...]
Summit Awarded up to $4.5 Million Grant from CARB-X for Development of New Mechanism Gonorrhoea Antibiotics
10/07/2018
Summit Therapeutics plc (‘Summit’ or the “’Company’) Summit Awarded up to $4.5 Million Grant from CARB-X for Development of New Mechanism Gonorrhoea Antibiotics Non-Dilutive Funding Could Support Development through [...]
Aptose Biosciences and CrystalGenomics Announce Issuance of Japanese Patent for CG-806
10/07/2018
SAN DIEGO, TORONTO, and SEOUL, July 10, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ:APTO) (TSX:APS), today announced that the Japan Patent Office has issued Japanese Patent No. [...]
Evogene Announces Positive Yield Results in its Bio-Stimulant Program for Wheat
10/07/2018
Product candidates have shown significant yield improvement in spring wheat field trials REHOVOT, Israel, July 10, 2018 (GLOBE NEWSWIRE) -- Evogene Ltd. (NASDAQ:EVGN) (TASE:EVGN), a leading biotechnology company [...]
Kamada Receives Positive Scientific Advice from European Medicines Agency on a New Phase 3 Study Design for Inhaled AAT
10/07/2018
Company Plans to Submit Clinical Trial Application and Intends to Engage in Discussions for Strategic European Partner for Commercialization Rights for Inhaled AAT REHOVOT, Israel, July 10, 2018 (GLOBE NEWSWIRE) -- [...]
miRagen Therapeutics Announces Initiation of Phase 2 Clinical Trial of MRG-201
10/07/2018
BOULDER, Colo., July 10, 2018 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (NASDAQ:MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced [...]
Amydis Receives Parkinson’s Disease Grant from Michael J. Fox Foundation
10/07/2018
SAN DIEGO, July 10, 2018 (GLOBE NEWSWIRE) -- Amydis, Inc., a privately-held pharmaceutical company developing proprietary chemistry and innovative approaches for the detection of amyloid-related diseases, announced [...]
AxoGen, Inc. Appoints Lisa N. Colleran to Board of Directors
10/07/2018
Health care industry veteran brings 30+ years of executive experience to AxoGen, Inc. Board of Directors ALACHUA, Fla., July 10, 2018 (GLOBE NEWSWIRE) -- AxoGen, Inc. (NASDAQ:AXGN), a global leader in developing and [...]
Arbutus Presents Corporate Update on Key Milestones
10/07/2018
First Subject Dosed in Phase 1 Study of AB-506, Arbutus’ Second-Generation Capsid Inhibitor All-Oral Combination Study of AB-506 and AB-452 Expected in 2019 HBsAg Reduction Data from ARB-1467 Expected in Q4 Arbutus [...]

Pages